A Phase II/III, Multicenter, Open-Label, Randomized Study of Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) To Evaluate Lot-To-Lot Consistency and to Compare Non-Inferiority with ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
Phase of Trial: Phase II/III
Latest Information Update: 04 Jul 2019
Price : $35 *
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary)
- Indications Rotavirus infections
- Focus Pharmacodynamics
- Sponsors Serum Institute of India
- 04 Apr 2019 Results published in the Vaccine
- 07 Sep 2018 Status changed from recruiting to completed.
- 13 Apr 2018 Planned primary completion date changed from 30 Jul 2018 to 20 Jun 2018.